Edgestream Partners, L.P. Corcept Therapeutics Inc Transaction History

Edgestream Partners, L.P.

  • $2.29 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$22.21 - $34.48 $816,772 - $1.27 Million
-36,775 Reduced 61.0%
23,516 $764,000
Q1 2024

May 10, 2024
BUY
$21.1 - $27.46 $1.27 Million - $1.66 Million
60,291 New
60,291 $1.52 Million
Q2 2023

Aug 10, 2023
BUY
$21.44 - $25.15 $617,214 - $724,018
28,788 New
28,788 $640,000

Others Institutions Holding CORT

# of Institutions
368
Shares Held
86.8M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.29B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email